Seroprevalence and incidence of hepatitis E virus among blood donors: A review

Reviews in Medical Virology

Volumn 27, Issue 5, 2017, Pages

  Al Sadeq, Duaa W ^a   Majdalawieh, Amin F ^b   Nasrallah, Gheyath K ^a,c  

^a Qatar University   (Qatar)

^b AMERICAN UNIVERSITY OF SHARJAH   (United Arab Emirates)

^c Qatar University   (Qatar)

Author keywords

blood donors; HEV; seroprevalence; transfusion; viremia

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 7; HEPATITIS E VIRUS GENOTYPE 8; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NORTH AFRICA; REVIEW; SEROPREVALENCE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 85028943538     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1937     Document Type: Review

References (133)

1. WHO. Hepatitis E. 2017; http://www.who.int/mediacentre/factsheets/fs280/en/. Accessed, January 1, 2017.
2. Science L. Hepatitis: Symptoms, Treatment & Prevention. 2015; http://www.livescience.com/34735-hepatitis-symptoms-treatment.html. Accessed, January 1, 2017.
3. CDC. Viral hepatitis - hepatitis E information. 2015; https://www.cdc.gov/hepatitis/hev/. Accessed, January 1, 2017.
4. Newsroom. A. Hepatitis E outbreak highlights the lack of adequate water and sanitation conditions among displaced population. 2017; http://www.africa-newsroom.com/press/diffa-niger-hepatitis-e-outbreak-highlights-the-lack-of-adequate-water-and-sanitation-conditions-among-displaced-population?lang=en. Accessed, January 1, 2017.
5. Khuroo MS, Khuroo MS. Sanitation and sewage disposal in India. JK-Practitioner. 2015;20(1-2):43-46.
6. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol. 2008;80(4):646-658.
7. Minuk G, Sun A, Sun D, et al. Serological evidence of hepatitis E virus infection in an indigenous North American population. Can J Gastroenterol Hepatol. 2007;21(7):439-442.
8. Abdelaal M, Zawawi T, Al Sobhi E, et al. Epidemiology of hepatitis E virus in male blood donors in Jeddah Saudi Arabia. Ir J Med Sci. 1998;167(2):94-96.
9. Johargy AK, Mahomed MF, Khan MM, Kabrah S. Anti hepatitis E virus seropositivity in a group of male blood donors in Makkah, Saudi Arabia. J Pak Med Assoc. 2013;63(2):185-189.
10. Pérez-Gracia MT, García M, Suay B, Mateos-Lindemann ML. Current knowledge on hepatitis E. J Clin Transl Hepatol. 2015;3(2):117
11. Wenzel JJ, Sichler M, Schemmerer M, Behrens G, Leitzmann MF, Jilg W. Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996-2011. Hepatology. 2014;60(4):1180-1186.
12. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008;358(8):859-860.
13. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. The Lancet. 2012;379(9835):2477-2488.
14. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116-138.
15. Lapa D, Capobianchi MR, Garbuglia AR. Epidemiology of hepatitis e virus in European countries. Int J Mol Sci. 2015;16(10):25711-25743.
16. Moghaddam SMH. Hepatitis E virus and renal transplantation. Hepat Mon. 2011;11(8):599.
17. Fierro NA, Realpe M, Meraz-Medina T, Roman S, Panduro A. Hepatitis E virus: an ancient hidden enemy in Latin America. World J Gastroenterol. 2016;22(7):2271.
18. Shrestha AC, Faddy HM, Flower RL, Seed CR, Keller AJ. Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history? Pathology. 2015;47(2):97.
19. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E in pregnant women and children in Iran: a general overview. J Clin Transl Hepatol. 2016;4(3):269.
20. Dreier J, Juhl D. Autochthonous hepatitis e virus infections: a new transfusion-associated risk? Transfus Med Hemother. 2013;41(1):29-39.
21. Tedder R. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang. 2011;102:272.
22. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. The Lancet. 2014;384(9956):1766-1773.
23. Cleland A, Smith L, Crossan C, et al. Hepatitis E virus in Scottish blood donors. Vox Sang. 2013;105(4):283-289.
24. O'Riordan J, Boland F, Williams P, et al. Hepatitis E virus infection in the Irish blood donor population. Transfusion. 2016;56(11):2868-2876.
25. Baylis S, Gärtner T, Nick S, Ovemyr J, Blümel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103(1):89-90.
26. Vollmer T, Diekmann J, Johne R, Eberhardt M, Knabbe C, Dreier J. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol. 2012;50(8):2708-2713.
27. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J, Gabriel C. Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS One. 2015;10(3):e0119576.
28. Slot E, Hogema B, Riezebos-Brilman A, Kok T, Molier M, Zaaijer H. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 2013;18(31):20550.
29. Gallian P, Lhomme S, Piquet Y, et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis. 2014;20(11):1914-1917.
30. Mansuy J, Saune K, Rech H, et al. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. Euro Surveill. 2015;20(119): pii21127.
31. Sauleda S, Ong E, Bes M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion. 2015;55(5):972-979.
32. Petrović T, Lupulović D, de Oya NJ, et al. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors. J Infect Dev Ctries. 2014;8(10):1322-1327.
33. Lucarelli C, Spada E, Taliani G, et al. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014. Euro Surveill. 2016;21(30):1-8.
34. Voronina O, Kunda M, Gudov V, et al. Search for RNA of the hepatitis E virus autochthonous for Russia in the most likely infection sources. Mol Gen Mikrobiol Virusol. 2013;29-34.
35. Passos-Castilho AM, de Sena A, Geraldo A, Spada C, Granato CF. High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil. J Med Virol. 2016;88(2):361-364.
36. Ibrahim E, Abdelwahab S, Nady S, et al. Prevalence of anti-HEV IgM among blood donors in Egypt. Egypt J Immunol. 2010;18(2):47-58.
37. Nasrallah GKAAE, Gandour R, Ali NH, Taleb S, Hedaya L, Ali F. Seroprevalence of hepatitis E virus among blood donors in Qatar. Transfusion. 2013-2016;2017.
38. Parsa R, Behbahani AB, Adibzadeh S, et al. Detection of hepatitis E virus genotype 1 among blood donors from southwest of Iran. Hepat Mon. 2016;16(6):e34202. https://doi.org/10.5812/hepatmon.34202
39. Minagi T, Okamoto H. Ikegawa M, et al. Vox Sang: Hepatitis E virus in donor plasma collected in Japan; 2016.
40. Ren F, Zhao C, Wang L, et al. Hepatitis E virus seroprevalence and molecular study among blood donors in China. Transfusion. 2014;54(3pt2):910-917.
41. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol. 2004;19(7):778-784.
42. Shrestha AC, Flower RL, Seed CR, et al. Hepatitis E virus RNA in Australian blood donations. Transfusion. 2016;
43. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis. 2008;47(8):1026-1031.
44. Olsen B, Axelsson-Olsson D, Thelin A, Weiland O. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis. 2006;38(1):55-58.
45. Holm DK, Moessner BK, Engle RE, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion. 2015;55(7):1662-1667.
46. Lange H, Øverbø J, Borgen K, et al. Hepatitis E in Norway: seroprevalence in humans and swine. Epidemiol Infect. 2016;1-6.
47. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008;20(8):784-790.
48. Beale M, Tettmar K, Szypulska R, Tedder R, Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang. 2011;100(3):340-342.
49. Juhl D, Baylis SA, Blumel J, Gorg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion. 2014;54(1):49-56.
50. Krumbholz A, Mohn U, Lange J, et al. Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol. 2012;201(2):239-244.
51. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol. 2007;45(6):2009-2010.
52. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol. 2008;80(2):289-293.
53. Kaufmann A, Kenfak-Foguena A, André C, et al. Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. PLoS One. 2011;6(6):e21150.
54. Scotto G, Martinelli D, Centra M, et al. Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy). Epidemiol Infect. 2014;142(02):287-294.
55. Fogeda M, Avellon A, Echevarria JM. Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid. Spain J Med Virol. 2012;84(1):71-74.
56. Macedo G, Pinto T, Sarmento JA, Vale A, Ribeiro T. The first assessment of hepatitis E virus seroprevalence in northern Portugal. Acta Med Port. 1998;11(12):1065-1068.
57. Takeda H, Matsubayashi K, Sakata H, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang. 2010;99(4):307-313.
58. Poovorawan Y, Theamboonlers A, Chumdermpadetsuk S, Komolmit P. Prevalence of hepatitis E virus infection in Thailand. Ann Trop Med Parasitol. 1996;90(2):189-196.
59. Vollmer T, Knabbe C, Dreier J. Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors. J Clin Microbiol. 2014;52(6):2150-2156.
60. Gupta E, Pandey P, Pandey S, Sharma MK, Sarin SK. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. J Clin Virol. 2013;58(2):374-377.
61. van Tong H, Hoan NX, Wang B, Wedemeyer H, Bock C-T, Velavan TP. Hepatitis E virus mutations: functional and clinical relevance. E Bio Medicine. 2016;11:31-42.
62. Wang S, Cheng X, Dai X, et al. Rabbit and human hepatitis E virus strains belong to a single serotype. Virus Res. 2013;176(1):101-106.
63. Colson P, Romanet P, Moal V, et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis. 2012;18(8):1361-1365.
64. Aggarwal R. Hepatitis E: historical, contemporary and future perspectives. J Gastroenterol Hepatol. 2011;26(s1):72-82.
65. Takahashi M, Nishizawa T, Sato H, Sato Y, Nagashima S, Okamoto H. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol. 2011;92(4):902-908.
66. Sato Y, Sato H, Naka K, et al. A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes. Arch Virol. 2011;156(8):1345-1358.
67. Khuroo MS, Khuroo MS, Khuroo NS. Transmission of hepatitis E virus in developing countries. Virus. 2016;8(9):253.
68. Woo PC, Lau SK, Teng JL, et al. New hepatitis E virus genotype in Bactrian Camels, Xinjiang, China, 2013. Emerg Infect Dis. 2016;22(12):2219.
69. Medscape. Hepatitis E. 2016; http://emedicine.medscape.com/article/178140-overview, 2016.
70. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton H. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol. 2008;80(1):95-101.
71. Dalton HR, Kamar N, van Eijk JJ, et al. Hepatitis E virus and neurological injury. Nat Rev Neurol. 2016;12(2):77-85.
72. Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med. 2014;6:45-59.
73. Ahmad T, Waheed Y, Tahir S, et al. Frequency of HEV contamination in sewerage waters in Pakistan. J Infect Dev Ctries. 2010;4(12):842-845.
74. Ceylan A, Ertem M, Ilcin E, Ozekinci T. A special risk group for hepatitis E infection: Turkish agricultural workers who use untreated waste water for irrigation. Epidemiol Infect. 2003;131(01):753-756.
75. Toole MJ, Claridge F, Anderson DA, et al. Hepatitis E virus infection as a marker for contaminated community drinking water sources in Tibetan villages. Am J Trop Med Hyg. 2006;74(2):250-254.
76. Sedyaningsih-Mamahit E, Larasati R, Laras K, et al. First documented outbreak of hepatitis E virus transmission in Java, Indonesia. Trans R Soc Trop Med Hyg. 2002;96(4):398-404.
77. Corwin AL, Tien NT, Bounlu K, et al. The unique riverine ecology of hepatitis E virus transmission in South-East Asia. Trans R Soc Trop Med Hyg. 1999;93(3):255-260.
78. Miyashita K, Kang JH, Saga A, et al. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: zoonotic food-borne transmission of hepatitis E virus and public health concerns. Hepatol Res. 2012;42(9):870-878.
79. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis. 2008;198(12):1732-1741.
80. Sonoda H, Abe M, Sugimoto T, et al. Prevalence of hepatitis E virus (HEV) Infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J Clin Microbiol. 2004;42(11):5371-5374.
81. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis. 2010;202(6):825-834.
82. Christou L, Kosmidou M. Hepatitis E virus in the western world—a pork-related zoonosis. Clin Microbiol Infect. 2013;19(7):600-604.
83. Feagins A, Opriessnig T, Guenette D, Halbur P, Meng X-J. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol. 2007;88(3):912-917.
84. Bouwknegt M, Lodder-Verschoor F, Van Der Poel WH, Rutjes SA, de Husman R, Mariade A. Hepatitis E virus RNA in commercial porcine livers in The Netherlands. J Food Prot. 2007;70(12):2889-2895.
85. Wenzel JJ, Preiß J, Schemmerer M, Huber B, Plentz A, Jilg W. Detection of hepatitis E virus (HEV) from porcine livers in southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol. 2011;52(1):50-54.
86. Di Bartolo I, Ponterio E, Castellini L, Ostanello F, Ruggeri FM. Viral and antibody HEV prevalence in swine at slaughterhouse in Italy. Vet Microbiol. 2011;149(3):330-338.
87. Tomiyama D, Inoue E, Osawa Y, Okazaki K. Serological evidence of infection with hepatitis E virus among wild Yezo-deer, Cervus Nippon Yesoensis, in Hokkaido, Japan. J Viral Hepat. 2009;16(7):524-528.
88. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. The Lancet. 2003;362(9381):371-373.
89. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido. Japan Transfusion. 2004;44(6):934-940.
90. Aggarwal R. Hepatitis E virus and person-to-person transmission. Clin Infect Dis. 2010;51(4):477-478.
91. Teshale EH, Grytdal SP, Howard C, et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in northern Uganda. Clin Infect Dis. 2010 Apr 1;50(7):1006-1010. https://doi.org/10.1086/651077
92. Howard CM, Handzel T, Hill VR, et al. Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am J Trop Med Hyg. 2010 Nov;83(5):1170-1173.
93. Yazbek S, Kreidieh K, Ramia S. Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety. Clin Microbiol. 2015;
94. Gurley ES, Halder AK, Streatfield PK, et al. Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am J Public Health. 2012;102(12):2248-2254.
95. Khuroo M, Kamili S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat. 2009;16(7):519-523.
96. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28-33.
97. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988-997.
98. Rasheeda CA, Navaneethan U, Jayanthi V. Liver disease in pregnancy and its influence on maternal and fetal mortality: a prospective study from Chennai, southern India. Eur J Gastroenterol Hepatol. 2008;20(4):362-364.
99. Stoszek SK, Abdel-Hamid M, Doa'a AS, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006;100(2):95-101.
100. Krain LJ, Atwell JE, Nelson KE, Labrique AB. Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg. 2014;90(2):365-370.
101. Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Physician. 2015;61(7):607-608.
102. Zaki MES, El Razek MMA, El Razek HMA. Maternal-fetal hepatitis E transmission: is it underestimated? J ClinTransl Hepatol. 2014;2(2):117.
103. Kar P. Hepatitis e virus infection during pregnancy: why is the disease stormy? Medicine. 2012;22.
104. Clayson ET, Innis BL, Myint K, et al. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am J Trop Med Hyg. 1995;53(3):228-232.
105. Meng X-J, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci. 1997;94(18):9860-9865.
106. Halbur P, Kasorndorkbua C, Gilbert C, et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol. 2001;39(3):918-923.
107. Pavio N, Meng X-J, Renou C. Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet Res. 2010;41(6):46.
108. Pavio N, Meng X-J, Doceul V. Zoonotic origin of hepatitis E. Curr Opin Virol. 2015;10:34-41.
109. Yugo DM, Meng X-J. Hepatitis E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health. 2013;10(10):4507-4533.
110. Woo P, Lau S, Teng J, et al. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis. 2014;20(1044): e8.
111. Abro AH, Abdou A, Saleh AA, Ustadi AM, Hussaini HS. Hepatitis E: a common cause of acute viral hepatitis. J Pak Med Assoc. 2009;59(2):92-94.
112. Huang F, Li Y, Yu W, et al. Excretion of infectious hepatitis E virus into milk in cows imposes high risks of zoonosis. Hepatology. 2016;64(2):350-359.
113. Kumar N, Sarin SK. Hepatitis E-is it a risk to transfusion safety? Asian J Transfus Sci. 2013;7(1):1.
114. Pawlotsky J-M. Hepatitis E screening for blood donations: an urgent need? The Lancet. 2014;384(9956):1729-1730.
115. Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74(4):563-572.
116. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med. 2006;16(2):79-83.
117. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37(2):113-120.
118. Lee G-H, Tan B-H, Teo EC-Y, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016;150(2):355-357. e353.
119. Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion. 2014;54(1):8-10.
120. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48(7):1368-1375.
121. Arankalle V, Chobe L. Retrospective analysis of blood transfusion recipients: evidence for post–transfusion hepatitis E. Vox Sang. 2000;79(2):72-74.
122. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17(12):2309-2312.
123. Shidrawi RG, Skidmore SJ, Coleman JC, et al. Hepatitis E an important cause of imported non-A non-B hepatitis among migrant workers in Qatar. J Med Virol. 1994;43:412-414.
124. Ibrahim AS, Alkhal A, Jacob J, et al. Hepatitis E in Qatar imported by expatriate workers from Nepal: epidemiological characteristics and clinical manifestations. J Med Virol. 2009;81:1047-1051.
125. Abro AH, Abdou AM, Saleh AA, Ustadi AM, Hussaini HS. Hepatitis E: a common cause of acute viral hepatitis. J Pak Med Assoc. 2009 Feb;59(2):92-94.
126. Bhat SK, Sachdeva VN, Saleem HI. Profile of viral hepatitis patients in Dakhliya, Oman. Saudi Med J. 2005;26:819-823.
127. Purcell R, Emerson S. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48(3):494-503.
128. Li T-C, Saito M, Ogura G, Ishibashi O, Miyamura T, Takeda N. Serologic evidence for hepatitis E virus infection in mongoose. Am J Trop Med Hyg. 2006;74(5):932-936.
129. Park HK, Jeong S-H, Kim J-W, et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis. 2012;12(1):142.
130. Coilly A, Haïm-Boukobza S, Roche B, et al. Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Transplantation. 2013;96(2):e4-e6.
131. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis. 2013;207(3):497-500.
132. Kodani M, Kamili NA, Tejada-Strop A, et al. Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E. J Med Virol. 2016;
133. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol. 2013;56(1):62-64.